Whole-body hyperthermia for depression

1. Introduction

Version followed: whole-body hyperthermia (WBH) as delivered in research and medically supervised clinic settings: the single-session, sham-controlled trial by Janssen, Raison and colleagues (JAMA Psychiatry 2016), the UCSF Osher Center pilot combining WBH with cognitive behavioural therapy (HeatBed; Mason et al., International Journal of Hyperthermia 2024), and the Essen sham-controlled HYPE I and HYPE II trials as reported in 2023. This guide is written for the psychotherapist around the procedure, not for delivering it.

WBH is a medical procedure in which a person lies in a heating device while research or clinical staff raise and then let down core body temperature under monitoring. The devices described differ: an enclosure heating the trunk with infrared light and the legs with heating coils (Arizona trial, as described in Moore 2016), a single-person infrared sauna dome covering the body except the head (UCSF), and chambers using water-filtered infrared-A lamps (the Hanusch group, Bern). [source: Janssen et al. 2016 abstract; Moore 2016; UCSF Osher news 2024; BFH 2025]

Core idea of change, as the investigators frame it (hypotheses, not established mechanisms): heat may act on thermosensory pathways linked to serotonergic brain systems and on immune signalling, and the body's cooling response afterwards may matter; immune changes after hyperthermia were reported to predict antidepressant response. The Essen group suggests it may suit subgroups such as stress- or immune-related depression. Hanusch suggests heat might ease the mental inertia of depression and so help clients take up psychotherapy. In the combined UCSF model, WBH is meant to give a fast mood shift that CBT then builds on. [source: Center for Healthy Minds study page; JAD Reports 2023 abstract; BFH 2025; Mason et al. 2024]

This is not something a psychotherapist delivers, and it is not something a client should try at home with a sauna, hot tub or bath. All of the reported work took place in screened, supervised research settings. [source: Janssen et al. 2016; HeatBed protocol 2024] [synthesis for the home-use caution]

2. Framework

Who delivers it

Research teams at university medical centres (Tucson, Arizona; UCSF Osher Center; Essen), with a physician acting as medical monitor who reviews every medicine the participant reports (HeatBed). [source: Janssen et al. 2016; HeatBed protocol 2024]
Clinic-based WBH in German-speaking countries is described with water-filtered infrared-A devices; the staffing and supervision rules of such clinics are not set out in the sources here. [uncertain: not verified]
The psychotherapist's place: assessment, referral, collaboration, preparing the client, delivering CBT alongside WBH where a trial or clinic builds it in, monitoring mood and safety, and integrating the experience. [source: Mason et al. 2024 for CBT alongside WBH] [synthesis for the rest]

Phases as the trials describe them

Recruitment and screening. Structured diagnostic interview for a current major depressive episode, a depression rating scale above a threshold, and medical and psychiatric exclusions (see Principles and Section 5). Arizona: medically healthy adults aged 18 to 65 with major depressive disorder and on no psychotropic medicine. HeatBed: adults with a current episode confirmed by the SCID and BDI-II above a cut-off, screened twice; people whose BDI-II fell by more than 30% between screenings were excluded. Essen: HYPE I took unmedicated patients; HYPE II took patients on stable antidepressants with no or partial response. [source: Janssen et al. 2016; HeatBed protocol; JAD Reports 2023]
Preparation. HeatBed asked participants to abstain from nicotine, cannabis and alcohol around sessions and to avoid heavy exercise on session days; medicines affecting heat regulation were exclusions. [source: HeatBed protocol]
Treatment sessions. Arizona: one active session versus a sham that matched it in length and in everything except intense heat. Essen: two WBH sessions within two weeks versus a waiting control. HeatBed: planned eight weekly WBH sessions, reduced partway through (with IRB approval) to four sessions every other week, alongside eight weekly 50-minute CBT sessions. [source: Janssen et al. 2016; JAD Reports 2023; HeatBed protocol; Mason et al. 2024]
Follow-up assessment. Arizona rated the HAM-D at weeks 1, 2, 4 and 6; HeatBed used repeated BDI-II self-reports and a final visit. [source: Janssen et al. 2016; Mason et al. 2024]
After the course. No source here sets out maintenance sessions or a relapse-prevention protocol after WBH. [uncertain: not verified]

Reported findings (as findings, not promises)

Janssen et al. 2016 (randomised, double-blind, sham-controlled; 34 randomised, 29 in the efficacy analysis): the WBH group had lower HAM-D scores than sham at every follow-up: about 6.5 points lower at week 1, 6.4 at week 2, 4.5 at week 4 and 4.3 at week 6. Adverse events were generally mild in both groups; headache, fatigue and dry mouth were the most common, with no significant group differences. Blinding was imperfect: 94% of the WBH group and 71% of the sham group believed they had received active treatment. The authors call WBH a promising, safe, rapid-acting treatment to be explored further. [source: Janssen et al. 2016 abstract; Moore 2016]
Earlier open trial: Hanusch et al. 2013 (American Journal of Psychiatry, 16 adults, no control) suggested a single session reduced symptoms. [source: Moore 2016] The Center for Healthy Minds page reports 60% response and 40% remission on the HDRS and immune effects predicting response; which study these figures come from is not stated there. [uncertain]
HeatBed (single arm, 16 adults): 13 of 16 completed at least four WBH sessions. Among the 12 at the final visit, BDI-II fell by a mean of 15.8 points and 11 of 12 no longer met criteria for major depressive disorder. Negative automatic thinking improved; cognitive flexibility did not. Mood improvement after the first WBH session predicted BDI-II change; mood change after the first CBT session did not. The authors stress the small sample and single-arm design. [source: Mason et al. 2024] The trial registration number is given differently across records (NCT05041361 on the protocol document; NCT05708976 in one abstract listing, which ClinicalTrials.gov titles "Study 2"). [uncertain]
Essen HYPE I and II (preliminary safety report, first 34 participants): WBH was well tolerated by most, with or without antidepressants; no serious side effects needing further treatment; risk of adverse effects during WBH was higher with physical comorbidities. Efficacy not yet reported in that abstract. [source: JAD Reports 2023]
A UCSF single-case report of the WBH plus CBT protocol was published in 2024 (Siwik et al., Advances in Integrative Medicine). [source: UCSF AME Center listing]

Evidence status

Experimental. One small sham-controlled RCT, open and single-arm pilots, and ongoing controlled trials. A 2016 clinical review judged it "too early to tell" and called for larger replication. Whether any national guideline includes WBH for depression: [uncertain: not verified]. Observational sauna cohorts (for example the Finnish research reviewed by Laukkanen et al. 2018) concern cardiovascular and other outcomes, not trials of depression treatment, and should not be cited to clients as proof that home heat treats depression. [source: Moore 2016; Laukkanen et al. 2018 abstract] [synthesis for the last point]

Criteria for moving between phases

Referral only after the client is medically assessed and judged eligible by the treating team; the psychotherapist does not decide medical eligibility. [synthesis]
Sessions go ahead only with stable psychiatric risk (HeatBed excluded active suicidal ideation and suicide attempts in the past year) and with the medicine review done by the physician. [source: HeatBed protocol]
Continue CBT through the WBH course; review mood after each heat session and before the next. [source: Mason et al. 2024 for concurrent delivery] [synthesis for the review step]

3. Guiding principles

It is a medical procedure in a supervised setting. Refer to research or clinic teams with a physician responsible; never coach a heat exposure yourself. [source: Janssen et al. 2016; HeatBed protocol]
No DIY home heat as self-treatment. Do not suggest saunas, hot tubs or hot baths as a substitute for WBH; trial participants were screened, monitored and had medicines reviewed, and home use has none of that. [synthesis]
Medicines belong to the prescriber. Never advise starting, stopping or changing an antidepressant or any other medicine, including to qualify for a trial; route every such question to the prescriber. CDC guidance warns against stopping medicines abruptly without a plan. [source: CDC heat and medications 2025] [synthesis]
Name the evidence honestly. Present it as promising and experimental, with small samples and imperfect blinding. [source: Moore 2016; Mason et al. 2024]
Respect the exclusions the trials used. Bipolar I disorder, psychosis, schizoaffective disorder, OCD, eating disorders, substance dependence, recent suicide attempt or active suicidal ideation (HeatBed); cardiovascular disease other than controlled hypertension, seizures, prior stroke, pregnancy and others (see Section 4.2). Practical meaning: these are flags for referral conversations, not decisions you make alone. [source: HeatBed protocol]
Bipolar spectrum needs extra caution. Bipolar I was an exclusion; whether WBH can trigger hypomania or mania has not been established in the sources here [uncertain: not verified]. Screen for a bipolar history and monitor for elevated mood after any rapid improvement. [synthesis]
Heat interacts with medicines. Lithium, antipsychotics, anticholinergics, tricyclics, SSRIs and SNRIs, stimulants, diuretics, beta blockers and other drugs affect sweating, fluid balance or blood pressure in heat (CDC). Practical meaning: make sure the medical team and prescriber know the full medicine list. [source: CDC heat and medications 2025]
Stay in your role and coordinate. Get consent to share information with the WBH team and prescriber; discuss parallel services with the client so roles stay clear (compare EABP Ethics Guidelines 6.b on parallel services). [source: EABP Ethics Guidelines 2020] [synthesis]
Use the mood window, don't over-credit the heat. The early post-heat mood shift predicted outcome in HeatBed; use it to start activation and cognitive work, and attribute lasting change to the client's own work too. [source: Mason et al. 2024] [synthesis]
Consent is informed and ongoing. The client may decline or stop WBH at any point without any effect on psychotherapy. [synthesis]
Plan for the effect fading. In the Arizona trial the difference from sham narrowed between weeks 2 and 6; build relapse prevention in from the start. [source: Janssen et al. 2016] [synthesis]

4. Intervention inventory

The sources describe the WBH procedure itself and the CBT given alongside it; they do not set out a psychotherapist protocol around WBH. Apart from the concurrent CBT in 4.7, the steps below are the psychotherapist's tasks built from the trial procedures and are marked [synthesis] where they go beyond them. Example language is illustrative throughout.

4.1 Psychoeducation and expectation-setting

Purpose / when: when a client asks about heat treatment for depression, has seen media or sauna-industry coverage, or is weighing a trial. [synthesis]
Steps: (1) Ask what they have read and where; sauna and infrared-device retailers publicise the UCSF work, so separate marketing from the trials. (2) Describe WBH plainly: a supervised medical procedure in a device, with screening and monitoring. (3) Give the findings as findings: one small sham-controlled trial with faster improvement than sham that narrowed over six weeks; a small single-arm pilot combined with CBT; ongoing controlled trials. (4) Name the common mild side effects reported (headache, fatigue, dry mouth). (5) Say what is unknown: long-term effects, who benefits, how it compares with standard treatments. (6) Explain why home saunas or hot tubs are not the same thing (4.4). [source: Janssen et al. 2016; Moore 2016; Mason et al. 2024; JAD Reports 2023] [synthesis for the sequence]
Example language (illustrative): "The research is interesting but early. In one small, carefully controlled study, people who had a single heat session under medical supervision improved faster than those who had a convincing fake session, and the difference narrowed over the following weeks. It's a research treatment, not a standard one yet."
Watch for: all-or-nothing hope ("this is the cure") or dismissal; plans to self-treat; pressure to drop current treatment. Working if the client can restate the evidence in their own words with its limits. [synthesis]

4.2 Screening before any referral conversation

Purpose / when: before suggesting a trial or clinic, so you flag likely problems early and route them to the medical team. [synthesis]
Steps: (1) Psychiatric history: bipolar disorder (especially bipolar I), psychosis or schizoaffective disorder, OCD, eating disorders, alcohol or drug dependence, suicide attempts in the past year and current suicidal ideation; these were HeatBed exclusions. (2) Current risk assessment using your usual standard practice. (3) Physical health the medical team will need to know about: cardiovascular disease, seizure disorder, prior stroke or other serious neurological conditions, current cancer, active infection, bleeding disorders, pregnancy or breastfeeding, breast implants, heat or infrared hypersensitivity; these were HeatBed exclusions too. (4) The full medicine list, including over-the-counter antihistamines and regular aspirin, and nicotine, cannabis and alcohol use. (5) Practical tolerance: claustrophobia, panic about bodily sensations, difficulty lying still. (6) Record what you found and pass it on with consent; the physician decides eligibility. [source: HeatBed protocol; CDC heat and medications 2025] [synthesis for steps 2, 5 and 6]
Example language (illustrative): "Before you contact the research team, it helps to know they'll ask about your heart, any seizures, pregnancy, all your medicines, and whether you've ever had periods of very high energy or little need for sleep. They make the medical decision; I'd like us to be ready for those questions."
Watch for: minimising or hiding history to qualify; hypomanic history that surfaces only on careful questioning; a rising risk picture. Working if the referral reaches the team with accurate information. [synthesis]

4.3 The medicine conversation: route to the prescriber

Purpose / when: whenever a client on antidepressants or other medicines considers WBH, since Arizona and HeatBed enrolled people off psychotropics or antidepressants, while Essen HYPE II enrolled people on stable antidepressants. [source: Janssen et al. 2016; HeatBed protocol; JAD Reports 2023]
Steps: (1) Do not advise starting, stopping, tapering or changing any medicine, including to qualify for a trial. (2) Explain that some trials take people on stable antidepressants and others do not, so a medicine change is never something to arrange on one's own. (3) Encourage the client to raise WBH with their prescriber, bringing the trial's information sheet. (4) Offer, with consent, to write to or speak with the prescriber about the psychological picture. (5) Note heat-related medicine issues as reasons for that conversation, not advice: CDC lists lithium, antipsychotics, anticholinergics, tricyclics, SSRIs and SNRIs, stimulants, diuretics, beta blockers and others as affecting heat tolerance. [source: CDC heat and medications 2025; trial sources above] [synthesis for steps 1 to 4]
Example language (illustrative): "Whether any medicine change makes sense is a decision for you and your prescriber, not for me and not for the trial. What I can do is help you get the question in front of them."
Watch for: stopping medicines without telling anyone; withdrawal or relapse symptoms; prescriber not informed. Working if the client and prescriber have discussed it before any decision. [synthesis]

4.4 Responding to DIY sauna, hot-tub or bath "self-treatment"

Purpose / when: when a client plans or is already using home heat to treat depression after media coverage. [synthesis]
Steps: (1) Ask what they are doing, without shaming. (2) Separate ordinary, enjoyable bathing customs from an attempt to copy a medical procedure. (3) Explain the differences: trial participants were screened for heart, neurological and other conditions, had medicines reviewed by a physician, abstained from alcohol and other substances around sessions, and were monitored throughout. (4) Name heat risks that apply to everyone: dehydration, fainting from low blood pressure, heat illness, and the added risks from alcohol, cannabis and medicines that affect heat regulation. (5) Do not give temperatures, durations or routines, and do not "make it safer" by coaching a protocol. (6) Suggest the client discuss any heat use with their GP or prescriber, especially with heart disease, pregnancy, seizures or relevant medicines. (7) If heat is a pleasant routine they already enjoy, it can stay a leisure and social activity, not a treatment, as their doctor advises. [source: HeatBed protocol; CDC heat and medications 2025] [synthesis for the steps]
Example language (illustrative): "The studies weren't a sauna at home. People were checked medically first, someone reviewed all their medicines, and staff watched them throughout. Trying to recreate that alone, especially with alcohol or certain medicines on board, carries real risks. If you enjoy the sauna, that's worth talking over with your doctor as a pastime, not as a treatment."
Watch for: escalating heat in pursuit of an effect; using heat while drinking; dizziness, fainting, confusion or palpitations reported after sessions (advise urgent medical help for heat-illness signs). Working if the client stops treating home heat as a therapy and checks with their doctor. [synthesis]

4.5 Referral to a trial or clinic and collaboration

Purpose / when: a client is interested, has had the medicine conversation, and the screen in 4.2 does not rule it out. [synthesis]
Steps: (1) Help the client find registered trials or medically supervised services (for example via ClinicalTrials.gov or a university centre). (2) Check that a named physician is responsible, that screening covers heart, neurological and medicine issues, and that adverse events are monitored. (3) Be wary of commercial offers using trial results to sell devices or sessions without medical screening. (4) Get written consent to share information both ways. (5) Agree how the WBH team will tell you about adverse events or risk, and how you will tell them about mood changes. (6) Clarify roles with the client so the parallel services do not confuse them. [source: HeatBed protocol; EABP Ethics Guidelines 2020 on parallel services] [synthesis]
Example language (illustrative): "If you go ahead, I'd like your permission to stay in touch with the team, so that if anything changes in your mood or your health, we're all working from the same picture."
Watch for: services that skip medical screening or promise cures; the client using the trial in place of all other support. Working if there is a clear shared plan and a named medical lead. [synthesis]

4.6 Preparing the client for the sessions

Purpose / when: after acceptance and before the first heat session. [synthesis]
Steps: (1) Describe what the research team will describe: lying in a device that warms the body, often with the head outside, with staff present and checks before, during and after. (2) Explore fears: heat, enclosure, sweating, being watched, undressing, body image. (3) For clients with trauma histories, plan how they will tell staff they want to stop and rehearse saying it; the right to stop is theirs. (4) For clients with panic or health anxiety, prepare for normal sensations of heat (faster heartbeat, sweating) and practise noticing them with curiosity; agree that symptoms which feel wrong are reported to staff at once. (5) Remind them of the team's own preparation rules (e.g. abstaining from alcohol, cannabis and nicotine around sessions in HeatBed). [source: UCSF Osher news 2024; HeatBed protocol] [synthesis for steps 2 to 4]
Example language (illustrative): "Heat makes your heart beat faster and makes you sweat; that's the body cooling itself. Let's practise naming those sensations, and let's also be clear that if anything feels wrong or you want to stop, you tell the staff straight away. You don't need a reason."
Watch for: high anticipatory anxiety, dissociation when imagining the enclosure, reluctance to speak up to staff. Working if the client can say what they will do if they want to stop. [synthesis]

4.7 CBT delivered alongside WBH (the UCSF integrated model)

Purpose / when: when you are the CBT therapist in a combined programme, or a client receives WBH from a medical team while in CBT with you. [source: Mason et al. 2024; HeatBed protocol]
What the sources specify: eight weekly 50-minute individual CBT sessions with a therapist, running alongside the WBH sessions (four sessions every other week in the revised schedule). The protocol calls the CBT a manualised, evidence-based treatment but does not name the manual or list its modules. Outcomes included negative automatic thoughts (improved) and cognitive flexibility (unchanged). [source: HeatBed protocol; Mason et al. 2024] [uncertain: which CBT manual and session content]
Steps (standard CBT for depression, arranged around the heat schedule) [synthesis]: (1) Session 1: formulation, psychoeducation about depression and about how CBT and WBH fit together, baseline self-report (the trial used the BDI-II), goals. (2) Early sessions: activity monitoring and behavioural activation; schedule valued and pleasant activities, especially for the days after a heat session. (3) Middle sessions: identifying and testing negative automatic thoughts with thought records and behavioural experiments; work on predictions such as "nothing will help me". (4) Later sessions: core beliefs where relevant, problem solving, and relapse-prevention planning. (5) Every session: brief mood rating and risk check, review of any heat session since the last meeting, homework review and setting.
Example language (illustrative): "Your heat session is on Thursday. Some people notice their mood lift for a few days afterwards. Shall we plan a couple of things for Friday and Saturday that you've been putting off, so we can see what happens when you act on that window?"
Watch for: homework completion, changes in BDI-II, whether gains appear in thinking as well as in mood. Working if the client is applying the skills between sessions and can describe changes in how they interpret events. [synthesis]

4.8 Using the post-session mood window

Purpose / when: in the days after a heat session. In HeatBed, mood improvement after the first WBH session predicted overall BDI-II change; Hanusch suggests heat may ease the inertia that keeps depressed clients from engaging. [source: Mason et al. 2024; BFH 2025]
Steps [synthesis]: (1) At the next session ask about mood, energy and sleep in the days after the heat session. (2) If the client noticed a lift, link it to concrete actions taken in that time. (3) If not, normalise it and avoid treating it as failure: the trials report group averages and not everyone improves. (4) Bring forward the most important activation or exposure tasks to coincide with any improvement. (5) Record the pattern across sessions.
Example language (illustrative): "You said Saturday felt lighter. What did you do with that lighter day? And what got in the way of doing more?"
Watch for: a lift that the client spends on catching up and then crashes; disappointment when no lift comes; signs of elevated mood beyond relief (see 4.9). Working if activation gains continue on days with no lift. [synthesis]

4.9 Monitoring mood, risk and adverse effects across the course

Purpose / when: throughout, since rapid mood change, side effects and risk shifts need passing on to the medical team. [synthesis]
Steps: (1) Brief standard depression self-report at agreed points (the trials used the HAM-D and BDI-II). (2) Ask about the side effects reported in the Arizona trial (headache, fatigue, dry mouth) and about dizziness, fainting, palpitations, confusion or prolonged exhaustion. (3) Screen for hypomanic signs after rapid improvement: reduced need for sleep, racing thoughts, unusual risk-taking, irritability. (4) Continue standard suicide risk assessment: rapid change in either direction can shift risk. (5) Pass any adverse effect, elevated mood or risk change to the WBH physician and prescriber, with consent, the same day if urgent. (6) Advise urgent medical help for signs of heat illness. [source: Moore 2016; Janssen et al. 2016; HeatBed protocol] [synthesis for steps 3 to 6]
Example language (illustrative): "Since the last session, have you had headaches, felt faint, or felt unusually wired, as if you didn't need sleep? Any of those I'd want to share with the medical team."
Watch for: under-reporting so as to stay in the trial; family reports that differ from the client's. Working if adverse effects reach the medical team promptly and mood ratings are tracked. [synthesis]

4.10 Integrating the experience and attributions

Purpose / when: during and after the course, so change is understood in a way that supports self-efficacy. [synthesis]
Steps [synthesis]: (1) Invite the client to describe the heat sessions in their own words: sensations, emotions, any memories or images. (2) Explore meanings: being cared for, enduring discomfort, letting go of control. (3) Help them attribute gains both to the treatment and to what they did with it. (4) Address expectancy openly: blinding in the Arizona trial was imperfect, and hope and attention matter; this does not make the client's improvement any less real. (5) Link bodily experiences to CBT targets (for example a sense of calm as evidence against "I can never feel better").
Example language (illustrative): "The heat may have given you a push, and you're the one who used it: you went back to the gym, you called your sister. Which of those do you want to keep doing whatever happens with the heat?"
Watch for: belief that only the heat helps (dependence on access to it); shame if it did not help. Working if the client names their own actions as part of the change. [synthesis]

4.11 Ending and relapse prevention

Purpose / when: before the last heat or CBT session, since the Arizona difference from sham narrowed over six weeks and no maintenance protocol is established. [source: Janssen et al. 2016] [uncertain: maintenance]
Steps [synthesis]: (1) Review gains with the self-report measures. (2) Write a relapse-prevention plan: early warning signs, helpful skills, people to contact, when to go back to the prescriber. (3) Agree follow-up. (4) If symptoms return, review with the prescriber and medical team rather than seeking unsupervised heat. (5) Write to the referrer and prescriber with the outcome, with consent.
Example language (illustrative): "Let's write down what tells you a slide is starting, and what you'll do in the first week if it does, including who you'll call, rather than trying to recreate the heat sessions on your own."
Watch for: the client planning home heat as a backup; avoidance of ending. Working if the plan is concrete and the client can say who they will contact. [synthesis]

5. Handling problems

The trial sources barely address these situations; everything below is [synthesis] unless a source is tagged.

Client wants to stop antidepressants to qualify for a trial. Do not advise on it either way. Explain that Essen's HYPE II took patients on stable antidepressants, so being on medicine does not rule out all research, and that any change is a decision with the prescriber. Offer to help prepare for that appointment. Language (illustrative): "That's a real question, and it belongs with your prescriber. Shall we write down what you want to ask?" [source: JAD Reports 2023 for HYPE II]
Client is already using a home sauna, hot tub or hot baths as "treatment". Use 4.4; no shaming, no protocol coaching, recommend a medical check, and ask explicitly about alcohol use alongside heat. If they report fainting, chest pain, palpitations or confusion, advise prompt medical assessment.
Client on lithium, antipsychotics, anticholinergics or other heat-sensitive medicines. Route to the prescriber and medical team; CDC lists these as affecting heat tolerance. Do not give "safer" home suggestions. [source: CDC heat and medications 2025]
Bipolar history or hypomanic signs after improvement. Bipolar I was a trial exclusion. If elevated mood appears, contact the prescriber and medical team promptly and pause further heat sessions pending their review; do not interpret it as simply "feeling better". [source: HeatBed protocol for the exclusion]
Cardiac disease, seizures, pregnancy or other medical exclusions. These were exclusions in HeatBed; the Essen group found adverse effects more likely with physical comorbidities. Validate the disappointment and redirect to standard treatments and to behavioural activation, which needs no heat. [source: HeatBed protocol; JAD Reports 2023]
Suicidal ideation rises or the client is at high risk. HeatBed excluded active suicidal ideation and recent attempts. Follow your usual risk-assessment and safety-planning practice; the trial is not a crisis option. Lethal-means conversations focus on safe storage and removal. [source: HeatBed protocol]
No response to WBH, or demoralisation ("even this didn't work"). Normalise: the reported results are averages from small samples. Separate the heat outcome from CBT progress, review activation data, and return to the prescriber about other evidence-based options.
Benefit fades after the course. The Arizona between-group difference narrowed over six weeks. Use the relapse-prevention plan (4.11); seek medical rather than DIY options for any further heat. [source: Janssen et al. 2016]
Panic, claustrophobia or trauma reactions during sessions. Prepare in advance (4.6); afterwards debrief, look for avoidance, and work on bodily sensations through standard CBT for panic if appropriate. The right to stop belongs to the client; tell the team about any reaction, with consent.
Body image, modesty or undressing concerns. Encourage the client to ask the team in advance what clothing and privacy arrangements exist, and to raise religious or gender-related needs. [uncertain: trial arrangements not described]
Under-reporting side effects or mood changes to stay in the trial. Address it gently, explain that safety information protects them, and agree what you will share.
Commercial providers or devices marketed with trial results. Help the client check for medical screening, a responsible physician and adverse-event monitoring; trial results do not transfer to home or retail use.
Non-adherence to CBT homework when the heat feels like "the real treatment". Revisit the combined rationale: in HeatBed, gains appeared in negative automatic thinking as well as mood. Set smaller homework tasks timed to the post-heat window (4.8). [source: Mason et al. 2024]
Rupture: the client sees you as a gatekeeper blocking a hopeful option. Acknowledge the hope, be transparent that eligibility decisions are medical, and keep the focus on shared goals. Language (illustrative): "I'm not trying to stop you. I want it done with the people who can check it's safe for you, and I'll help you get there."
Expectancy and placebo questions. If the client asks whether it is "just placebo", say the Arizona trial used a convincing sham and still found a difference, while blinding was imperfect and samples small. [source: Janssen et al. 2016; Moore 2016]

Sources

Web sources:

Articles cited:

Janssen CW, Lowry CA, Mehl MR, Allen JJB, et al., Raison CL (2016). Whole-body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial. JAMA Psychiatry 73(8):789-795. doi:10.1001/jamapsychiatry.2016.1031
Mason AE, Chowdhary A, Hartogensis W, et al., Raison CL, Hecht FM (2024). Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT). International Journal of Hyperthermia 41(1). doi:10.1080/02656736.2024.2351459
Siwik CJ, et al., Mason AE (2024). Treating major depressive disorder with an integrated mind-body intervention: whole-body hyperthermia and cognitive behavioral therapy, a case report. Advances in Integrative Medicine.
Laukkanen JA, Laukkanen T, Kunutsor SK (2018). Cardiovascular and other health benefits of sauna bathing: a review of the evidence. Mayo Clinic Proceedings 93(8):1111-1121. doi:10.1016/j.mayocp.2018.04.008
Hanusch KU, et al. (2013). Open-label study of a single WBH session in 16 adults with depression, American Journal of Psychiatry, as cited in Moore 2016. [uncertain: full citation not verified]
Essen HYPE I and HYPE II safety report (2023), Journal of Affective Disorders Reports. [uncertain: authors not verified]
Knobel (2022), cited in the BFH article as a study of WBH in depression. [uncertain: not verified]

← Previous · X-193Korean jjimjilbang Next · X-196 →Cold-water immersion, ice baths and winter swimming